126 related articles for article (PubMed ID: 25530340)
1. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
[TBL] [Abstract][Full Text] [Related]
2. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
4. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
5. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
Li ZM; Zhang HY; Wang YX; Wang WB
J Drug Target; 2016; 24(2):102-10. PubMed ID: 26302771
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
[TBL] [Abstract][Full Text] [Related]
11. Protein inhibitor of activated STAT xα depresses cyclin D and cyclin D kinase, and contributes to the inhibition of osteosarcoma cell progression.
Wang J; Ni J; Yi S; Song D; Ding M
Mol Med Rep; 2016 Feb; 13(2):1645-52. PubMed ID: 26708148
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
13. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
Wang Y; Fu Q; Zhao W
Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway.
Wang WG; Chen SJ; He JS; Li JS; Zang XF
Tumour Biol; 2016 Jul; 37(7):8869-77. PubMed ID: 26750098
[TBL] [Abstract][Full Text] [Related]
15. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
Yu X; Pang L; Yang T; Liu P
Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
[TBL] [Abstract][Full Text] [Related]
16. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
17. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
Fan YZ; Zhao ZM; Fu JY; Chen CQ
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):618-22. PubMed ID: 16784656
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.
Wu J; Zhong D; Fu X; Liu Q; Kang L; Ding Z
Int J Mol Sci; 2014 Apr; 15(4):5570-81. PubMed ID: 24694542
[TBL] [Abstract][Full Text] [Related]
19. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
Zhang C; Zhao Y; Zeng B
Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
[TBL] [Abstract][Full Text] [Related]
20. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
Wang Z; Xia Q; Cui J; Diao Y; Li J
Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
